General Information
Revision date
2019-03-18
Product name
Doxercalciferol Injection
Manufacturer Name
Gland Pharma Limited
Icons in SDS
Company Information
company name
Lupin Pharmaceuticals, Inc
Section 2
SECTION 2: Hazards identification
Fire and Explosion Expected to be non-combustible. Health Doxercalciferol should not be given to patients with a tendency towards hypercalcemia or current evidence of vitamin D toxicity. Doxercalciferol injection is contraindicated in patients with previous hypersensitivity to doxercalciferol or any of its ingredients
Environmental hazards
No information is available about the potential of this product to produce adverse environmental effects.
